PUB - Publikationen an der Universität Bielefeld

Defective Protein Catabolism in Atherosclerotic Vascular Inflammation.
Miyazaki T, Miyazaki A., Front Cardiovasc Med 4(), 2017
PMID: 29270409

Transcriptional Profiling of Foam Cells Reveals Induction of Guanylate-Binding Proteins Following Western Diet Acceleration of Atherosclerosis in the Absence of Global Changes in Inflammation.
Goo YH, Son SH, Yechoor VK, Paul A., J Am Heart Assoc 5(4), 2016
PMID: 27091181

Edaravone attenuates monocyte adhesion to endothelial cells induced by oxidized low-density lipoprotein.
Li Z, Cheng J, Wang L., Biochem Biophys Res Commun 466(4), 2015
PMID: 26348774

New paradigms in inflammatory signaling in vascular endothelial cells.
Xiao L, Liu Y, Wang N., Am J Physiol Heart Circ Physiol 306(3), 2014
PMID: 24285111

The extrinsic coagulation cascade and tissue factor pathway inhibitor in macrophages: a potential therapeutic opportunity for atherosclerotic thrombosis.
Jiang P, Xue D, Zhang Y, Ye L, Liu Y, Makale M, Kesari S, Edgington TS, Liu C., Thromb Res 133(4), 2014
PMID: 24485401

Oxidized low-density lipoprotein suppresses expression of prostaglandin E receptor subtype EP3 in human THP-1 macrophages.
Sui X, Liu Y, Li Q, Liu G, Song X, Su Z, Chang X, Zhou Y, Liang B, Huang D., PLoS One 9(10), 2014
PMID: 25333975

Whole-exome sequencing and imaging genetics identify functional variants for rate of change in hippocampal volume in mild cognitive impairment.
Nho K, Corneveaux JJ, Kim S, Lin H, Risacher SL, Shen L, Swaminathan S, Ramanan VK, Liu Y, Foroud T, Inlow MH, Siniard AL, Reiman RA, Aisen PS, Petersen RC, Green RC, Jack CR, Weiner MW, Baldwin CT, Lunetta K, Farrer LA, Multi-Institutional Research on Alzheimer Genetic Epidemiology (MIRAGE) Study, Furney SJ, Lovestone S, Simmons A, Mecocci P, Vellas B, Tsolaki M, Kloszewska I, Soininen H, AddNeuroMed Consortium, McDonald BC, Farlow MR, Ghetti B, Indiana Memory and Aging Study, Huentelman MJ, Saykin AJ, Alzheimer's Disease Neuroimaging Initiative (ADNI)., Mol Psychiatry 18(7), 2013
PMID: 23608917

Monocytic expression of osteoclast-associated receptor (OSCAR) is induced in atherosclerotic mice and regulated by oxidized low-density lipoprotein in vitro.
Sinningen K, Rauner M, Goettsch C, Al-Fakhri N, Schoppet M, Hofbauer LC., Biochem Biophys Res Commun 437(2), 2013
PMID: 23817038

Conjugated linoleic acid isomers may diminish human macrophages adhesion to endothelial surface.
Stachowska E, Siennicka A, Baśkiewcz-Hałasa M, Bober J, Machalinski B, Chlubek D., Int J Food Sci Nutr 63(1), 2012
PMID: 21721848

Suppression of oxLDL-induced MMP-9 and EMMPRIN expression by berberine via inhibition of NF-κB activation in human THP-1 macrophages.
Huang Z, Meng S, Wang L, Wang Y, Chen T, Wang C., Anat Rec (Hoboken) 295(1), 2012
PMID: 22140092

OxLDL inhibits LPS-induced IFNβ expression by Pellino3- and IRAK1/4-dependent modification of TANK.
Tzieply N, Kuhn AM, Morbitzer D, Namgaladze D, Heeg A, Schaefer L, von Knethen A, Jensen LE, Brüne B., Cell Signal 24(6), 2012
PMID: 22330071

Myeloid IκBα deficiency promotes atherogenesis by enhancing leukocyte recruitment to the plaques.
Goossens P, Vergouwe MN, Gijbels MJ, Curfs DM, van Woezik JH, Hoeksema MA, Xanthoulea S, Leenen PJ, Rupec RA, Hofker MH, de Winther MP., PLoS One 6(7), 2011
PMID: 21814576

Comparison of anti-atherosclerotic effects of two different extracts from leaves of Mallotus furetianus.
Yueli L, Liqun W, Haitao W, Lianbo L, Xinan Y., Asian Pac J Trop Med 4(11), 2011
PMID: 22078950

Regulation of IkappaBalpha function and NF-kappaB signaling: AEBP1 is a novel proinflammatory mediator in macrophages.
Majdalawieh A, Ro HS., Mediators Inflamm 2010(), 2010
PMID: 20396415

Nuclear factor kappa-light-chain-enhancer of activated B cells (NF-κB): a new potential therapeutic target in atherosclerosis?
Dąbek J, Kułach A, Gąsior Z., Pharmacol Rep 62(5), 2010
PMID: 21098861

oxLDL uptake by dendritic cells induces upregulation of scavenger-receptors, maturation and differentiation.
Nickel T, Schmauss D, Hanssen H, Sicic Z, Krebs B, Jankl S, Summo C, Fraunberger P, Walli AK, Pfeiler S, Weis M., Atherosclerosis 205(2), 2009
PMID: 19203752

Low vasa vasorum densities correlate with inflammation and subintimal thickening: potential role in location--determination of atherogenesis.
Gössl M, Versari D, Lerman LO, Chade AR, Beighley PE, Erbel R, Ritman EL., Atherosclerosis 206(2), 2009
PMID: 19368925

Role of inflammation in atherosclerosis associated with rheumatoid arthritis.
Libby P., Am J Med 121(10 suppl 1), 2008
PMID: 18926166

Increased tissue transglutaminase expression in human atherosclerotic coronary arteries.
Cho BR, Kim MK, Suh DH, Hahn JH, Lee BG, Choi YC, Kwon TJ, Kim SY, Kim DJ., Coron Artery Dis 19(7), 2008
PMID: 18923241

Inflammation at the molecular interface of atherogenesis: an anthropological journey.
Lamon BD, Hajjar DP., Am J Pathol 173(5), 2008
PMID: 18948435

High tissue factor-expressing human monocytes carry low surface CD36: application to intersubject variability.
Sovershaev MA, Egorina EM, Gruber FX, Olsen JO, Osterud B., J Thromb Haemost 5(12), 2007
PMID: 17900273

Effects of soy pinitol on the pro-inflammatory cytokines and scavenger receptors in oxidized low-density lipoprotein-treated THP-1 macrophages.
Choi MS, Lee WH, Kwon EY, Kang MA, Lee MK, Park YB, Jeon SM., J Med Food 10(4), 2007
PMID: 18158828

Adriamycin promotes macrophage dysfunction in mice.
Asmis R, Qiao M, Rossi RR, Cholewa J, Xu L, Asmis LM., Free Radic Biol Med 41(1), 2006
PMID: 16781464

Endothelial dysfunction and activation as an expression of disease: role of prostacyclin analogs.
Zardi EM, Zardi DM, Cacciapaglia F, Dobrina A, Amoroso A, Picardi A, Afeltra A., Int Immunopharmacol 5(3), 2005
PMID: 15683843

Enhanced plasma levels of oxidized low-density lipoprotein increase circulating nuclear factor-kappa B activation in patients with unstable angina.
Cominacini L, Anselmi M, Garbin U, Fratta Pasini A, Stranieri C, Fusaro M, Nava C, Agostoni P, Keta D, Zardini P, Sawamura T, Lo Cascio V., J Am Coll Cardiol 46(5), 2005
PMID: 16139128

Dual role of oxidized LDL on the NF-kappaB signaling pathway.
Robbesyn F, Salvayre R, Negre-Salvayre A., Free Radic Res 38(6), 2004
PMID: 15346645

Activation of nuclear factor-kappaB and correlation with elevated plasma c-reactive protein in patients with unstable angina.
Li JJ, Fang CH, Chen MZ, Chen X, Lee SW., Heart Lung Circ 13(2), 2004
PMID: 16352190

Role of vasa vasorum in transendothelial solute transport in the coronary vessel wall: a study with cryostatic micro-CT.
Gössl M, Beighley PE, Malyar NM, Ritman EL., Am J Physiol Heart Circ Physiol 287(5), 2004
PMID: 15178545

Involvement of NF-kappaB signalling in skin physiology and disease.
Bell S, Degitz K, Quirling M, Jilg N, Page S, Brand K., Cell Signal 15(1), 2003
PMID: 12401514

Hematein inhibits atherosclerosis by inhibition of reactive oxygen generation and NF-kappaB-dependent inflammatory mediators in hyperlipidemic mice.
Choi JH, Jeong TS, Kim DY, Kim YM, Na HJ, Nam KH, Lee SB, Kim HC, Oh SR, Choi YK, Bok SH, Oh GT., J Cardiovasc Pharmacol 42(2), 2003
PMID: 12883334

Anti-inflammatory properties of lipid oxidation products.
Bochkov VN, Leitinger N., J Mol Med (Berl) 81(10), 2003
PMID: 13679995

Toll-like receptor expression in human keratinocytes: nuclear factor kappaB controlled gene activation by Staphylococcus aureus is toll-like receptor 2 but not toll-like receptor 4 or platelet activating factor receptor dependent.
Mempel M, Voelcker V, Köllisch G, Plank C, Rad R, Gerhard M, Schnopp C, Fraunberger P, Walli AK, Ring J, Abeck D, Ollert M., J Invest Dermatol 121(6), 2003
PMID: 14675188

Upregulation of interleukin-8 expression by prostaglandin D2 metabolite 15-deoxy-delta12, 14 prostaglandin J2 (15d-PGJ2) in human THP-1 macrophages.
Fu Y, Luo N, Lopes-Virella MF., Atherosclerosis 160(1), 2002
PMID: 11755918

The role of chemokines in human cardiovascular pathology: enhanced biological insights.
Shin WS, Szuba A, Rockson SG., Atherosclerosis 160(1), 2002
PMID: 11755926

Nuclear factor-kappaB immunoreactivity is present in human coronary plaque and enhanced in patients with unstable angina pectoris.
Wilson SH, Best PJ, Edwards WD, Holmes DR, Carlson PJ, Celermajer DS, Lerman A., Atherosclerosis 160(1), 2002
PMID: 11755932

Alpha1-antichymotrypsin/Alzheimer's peptide Abeta(1-42) complex perturbs lipid metabolism and activates transcription factors PPARgamma and NFkappaB in human neuroblastoma (Kelly) cells.
Sun YX, Wright HT, Janciauskiene S., J Neurosci Res 67(4), 2002
PMID: 11835318

Increased IkappaB kinase activity is associated with activated NF-kappaB in acute myeloid blasts.
Baumgartner B, Weber M, Quirling M, Fischer C, Page S, Adam M, Von Schilling C, Waterhouse C, Schmid C, Neumeier D, Brand K., Leukemia 16(10), 2002
PMID: 12357358

Decreased inducibility of TNF expression in lipid-loaded macrophages.
Ares MP, Stollenwerk M, Olsson A, Kallin B, Jovinge S, Nilsson J., BMC Immunol 3(), 2002
PMID: 12366867

Chlamydia pneumoniae activates IKK/I kappa B-mediated signaling, which is inhibited by 4-HNE and following primary exposure.
Donath B, Fischer C, Page S, Prebeck S, Jilg N, Weber M, da Costa C, Neumeier D, Miethke T, Brand K., Atherosclerosis 165(1), 2002
PMID: 12208473

Atherogenesis in perspective: hypercholesterolemia and inflammation as partners in crime.
Steinberg D., Nat Med 8(11), 2002
PMID: 12411947

Oxidized low-density lipoprotein-induced apoptosis.
Salvayre R, Auge N, Benoist H, Negre-Salvayre A., Biochim Biophys Acta 1585(2-3), 2002
PMID: 12531556

Effect of hypercholesterolemia on macrophage infiltration after balloon injury to rabbit iliac artery.
Song JM, Kim HS, Park SJ, Chae IH, Oh BH, Lee MM, Park YB., Jpn Circ J 65(2), 2001
PMID: 11216820

NF-kappaB: pivotal mediator or innocent bystander in atherogenesis?
Collins T, Cybulsky MI., J Clin Invest 107(3), 2001
PMID: 11160146

[Cellular and molecular biology of atherosclerotic lesions]
Martínez-González J, Llorente-Cortés V, Badimon L., Rev Esp Cardiol 54(2), 2001
PMID: 11181311

Characterization of peroxynitrite-oxidized low density lipoprotein binding to human CD36.
Guy RA, Maguire GF, Crandall I, Connelly PW, Kain KC., Atherosclerosis 155(1), 2001
PMID: 11223422

t-Butyl hydroperoxide and oxidized low density lipoprotein enhance phospholipid hydrolysis in lipopolysaccharide-stimulated retinal pericytes.
Lupo G, Anfuso CD, Ragusa N, Strosznajder RP, Walski M, Alberghina M., Biochim Biophys Acta 1531(1-2), 2001
PMID: 11278179

The effect of endothelin-1 on nuclear factor kappa B in macrophages.
Wilson SH, Simari RD, Lerman A., Biochem Biophys Res Commun 286(5), 2001
PMID: 11527395

Enzymatically degraded low density lipoproteins are more potent inducers of egr-1 mRNA than oxidized or native low density lipoproteins.
Stoyanova E, Tesch A, Armstrong VW, Wieland E., Clin Biochem 34(6), 2001
PMID: 11676978

Activated nuclear factor-kappaB is present in the coronary vasculature in experimental hypercholesterolemia.
Wilson SH, Caplice NM, Simari RD, Holmes DR, Carlson PJ, Lerman A., Atherosclerosis 148(1), 2000
PMID: 10580167

Platelets induce alterations of chemotactic and adhesive properties of endothelial cells mediated through an interleukin-1-dependent mechanism. Implications for atherogenesis.
Gawaz M, Brand K, Dickfeld T, Pogatsa-Murray G, Page S, Bogner C, Koch W, Schömig A, Neumann F., Atherosclerosis 148(1), 2000
PMID: 10580173

Oxidized LDLs alter the activity of the ubiquitin-proteasome pathway: potential role in oxidized LDL-induced apoptosis.
Vieira O, Escargueil-Blanc I, Jürgens G, Borner C, Almeida L, Salvayre R, Nègre-Salvayre A., FASEB J 14(3), 2000
PMID: 10698969

Oxidized phospholipids activate PPARalpha in a phospholipase A2-dependent manner.
Delerive P, Furman C, Teissier E, Fruchart J, Duriez P, Staels B., FEBS Lett 471(1), 2000
PMID: 10760508

Role of reactive aldehyde in cardiovascular diseases.
Uchida K., Free Radic Biol Med 28(12), 2000
PMID: 10946210

A model to study antioxidant regulation of endotoxemia-modulated neonatal granulopoiesis and granulocyte apoptosis.
Yang KD, Chen MZ, Teng RJ, Yang MY, Liu HC, Chen RF, Hsu TY, Shaio MF., Pediatr Res 48(6), 2000
PMID: 11102554

Mildly oxidized low-density lipoproteins decrease early production of interleukin 2 and nuclear factor kappaB binding to DNA in activated T-lymphocytes.
Caspar-Bauguil S, Tkaczuk J, Haure MJ, Durand M, Alcouffe J, Thomsen M, Salvayre R, Benoist H., Biochem J 337 ( Pt 2)(), 1999
PMID: 9882624

gamma-tocopherol decreases ox-LDL-mediated activation of nuclear factor-kappaB and apoptosis in human coronary artery endothelial cells.
Li D, Saldeen T, Mehta JL., Biochem Biophys Res Commun 259(1), 1999
PMID: 10334932

Involvement of nuclear factor-kappaB in a murine model for the acute form of autoimmune-like toxic oil syndrome.
Bell SA, Page S, Baumgartner B, Berking C, Haas M, Eisele T, Neumeier D, Brand K., Toxicol Appl Pharmacol 157(3), 1999
PMID: 10373405

Diverse agents act at multiple levels to inhibit the Rel/NF-kappaB signal transduction pathway.
Epinat JC, Gilmore TD., Oncogene 18(49), 1999
PMID: 10602465

The nuclear factor-kappa B/inhibitor of kappa B autoregulatory system and atherosclerosis.
Thurberg BL, Collins T., Curr Opin Lipidol 9(5), 1998
PMID: 9812192

Chemokines and atherosclerosis.
Terkeltaub R, Boisvert WA, Curtiss LK., Curr Opin Lipidol 9(5), 1998
PMID: 9812193

Recent progress in defining the role of scavenger receptors in lipid transport, atherosclerosis and host defence.
Greaves DR, Gough PJ, Gordon S., Curr Opin Lipidol 9(5), 1998
PMID: 9812196

Complementary roles for scavenger receptor A and CD36 of human monocyte-derived macrophages in adhesion to surfaces coated with oxidized low-density lipoproteins and in secretion of H2O2.
Maxeiner H, Husemann J, Thomas CA, Loike JD, El Khoury J, Silverstein SC., J Exp Med 188(12), 1998
PMID: 9858512